InsidersTradesSigma
Track the Aspire Biopharma Holdings, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 10 June 2025 (Acquisition). Among the most active insiders: Fell Donald G.. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Aspire Biopharma Holdings, Inc. 是一家专注于开发生物制药疗法的公司。该公司在 XNAS 市场上市。